✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

GKB Ophthalmics Ltd.

GKB

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹27 Cr.
P/E
0.00

GKB Ophthalmics Ltd.

  • GKB Ophthalmics
  • Galaxy Medicare
  • Centenial Surgical

FAQs on GKB Ophthalmics Ltd. Shareprice

GKB Ophthalmics has given lower returns compared to its competitors.
GKB Ophthalmics has grown at ~-47.68% over the last 1yrs while peers have grown at a median rate of -17.0%

GKB Ophthalmics is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of GKB Ophthalmics is 0.0, while 3 year average PE is 11.3.
Also latest EV/EBITDA of GKB Ophthalmics is 313 while 3yr average is 70.04.

View FAQ's On Business

Growth Table

  • GKB Ophthalmics Ltd.
  • Galaxy Medicare
  • Centenial Surgical

Balance Sheet

  • GKB Ophthalmics Ltd.
  • Galaxy Medicare
  • Centenial Surgical

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • GKB Ophthalmics Ltd.
  • Galaxy Medicare
  • Centenial Surgical

Cash Flow

  • GKB Ophthalmics Ltd.
  • Galaxy Medicare
  • Centenial Surgical

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • GKB Ophthalmics Ltd.
  • Galaxy Medicare
  • Centenial Surgical

Quarterly Results

  • GKB Ophthalmics Ltd.
  • Galaxy Medicare
  • Centenial Surgical

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on GKB Ophthalmics Ltd. Financials

GKB Ophthalmics balance sheet is weak and might have solvency issues

Yes, The net debt of GKB Ophthalmics is increasing.
Latest net debt of GKB Ophthalmics is ₹1.28 Crs as of Sep-25.
This is greater than Mar-25 when it was -₹13.09 Crs.

The profit is oscillating.
The profit of GKB Ophthalmics is -₹4.77 Crs for TTM, -₹7.04 Crs for Mar 2025 and -₹2.81 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
GKB Ophthalmics latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech